News and Trends 18 Jul 2023
Boost for Charcot-Marie-Tooth patients as Novartis acquires DTx Pharma
DTx Pharma, a preclinical stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its fatty acid ligand conjugated oligonucleotide (FALCON) platform, has been acquired by Novartis. The FALCON…